Sofgen Pharma (PROCF) Stock Price
Sofgen Pharma Price
Over the last 5 years Sofgen Pharma grew revenue by 2.8% annually, reaching 373.80 M USD. For Sofgen Pharma, the net margin of -18.3% is down versus -3.1% a few years ago.
Sofgen Pharma stock price
Sofgen Pharma business model & stock analysis
Frequently asked questions about Sofgen Pharma
8 analysts currently rate the Sofgen Pharma stock: 0 recommend buying, 3 holding and 5 selling.
Converted at the current exchange rate, the Sofgen Pharma share trades at 0.01 EUR (0.01 USD).
The Sofgen Pharma share (PROCF) is listed on 2 stock exchanges, including: NASDAQ (PROC), Frankfurt (9X1.F).
The revenue cannot currently be calculated for Sofgen Pharma.
The profit cannot currently be calculated for Sofgen Pharma.
The P/E ratio cannot be calculated for Sofgen Pharma at the moment.
The P/S cannot be calculated for Sofgen Pharma currently.
The Eulerpool Quality Score for Sofgen Pharma is 1/10.
The ISIN of Sofgen Pharma is LU2376511205. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Sofgen Pharma is A3C4K9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Sofgen Pharma is PROCF. The ticker symbol is used to trade Sofgen Pharma shares on the stock exchange.
Sofgen Pharma stock
Sofgen Pharma Peer Group
Sofgen Pharma Ticker
Sofgen Pharma FIGI
All fundamentals and in-depth analysis of Sofgen Pharma
Our stock analysis for Sofgen Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sofgen Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.